跳至主要内容
临床试验/NCT01603017
NCT01603017已完成不适用

Nuclear Magnetic Resonance Therapy in Knee Osteoarthrosis: A Double Blind Ranomised Controlled Trial

NHS Grampian2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2007年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
NHS Grampian
入组人数
100
试验地点
2
主要终点
Oxford Knee Score

研究概览

简要总结

Nuclear Magnetic Resonance Therapy (NMRT) is gaining as a novel mode of therapy in osteoarthrosis. A prospective double blind randomised study of 100 patients was conducted to investigate efficacy of NMRT in the treatment of mild to moderate osteoarthrosis (OA) of the knee joint.

The null hypothesis was that there is no benefit of NMRT over placebo in mild to moderate oteoarthosis of the knee.

详细描述

This study was approved by the Regional Ethics Committee. Patients were recruited from referrals made by General Practitioners to a single Orthopaedic Outpatient Department between October 2007 and February 2008. The study was a prospective placebo controlled, double blind randomised mono centric study with a follow up period of 6 months.

All potential trial participants demonstrated symptomatic mild to moderate OA of the knee joint diagnosed by an experienced consultant orthopaedic surgeon. Radiographic evidence was gathered by means of standard clinical standing antero-posterior and lateral radiographs of the knee.

Baseline assessment included :

  1. clinical examination
  2. active Range of movement
  3. plain radiographs
  4. WOMAC osteoarthritis index
  5. Oxford Knee Score (OKS)
  6. Severity of pain VAS.
  7. Strength and frequency of any painkillers taken.
  8. Phyasiotherapy Study design was directed at use of NMRT in a clinical setting. It was therefore considered valid to not restrict the use of the pain killers and physiotherapy. Positional Magnetic Resonance Imaging (pMRI) scan of the knee joint was undertaken.

Randomisation was carried out by means of visually identical computer chip cards numbered from 1 to 100 which had been independently programmed by the manufacturer. Thus, half of the computer chip cards (n=50) were programmed to activate the magnetic fields (= treatment group) and remaining half (n=50) were programmed not to activate magnetic fields (=placebo group) of the device. The research team and patients were blinded to the programmed activity of the cards. The magnetic resonance indicator LED lamp on the device was disabled by the manufacturer to ensure that the operator and patients were blinded to the therapy status. Every patient entering the study was asked to choose a numbered card from those available, and this card was then used to operate the device for that specific patient for all five sessions of NMRT.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Osteoarthrosis of the knee(s)
  • Moderately severe (grade 1-2)

排除标准

  • Prior knee surgery
  • Implanted metallic devices

结局指标

主要结局

Oxford Knee Score

时间窗: 12 weeks

Patient administered validated questions

次要结局

未报告次要终点

研究者

发起方
NHS Grampian
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

S Barker

Consultant Orthopaedic Surgeon

NHS Grampian

研究点 (2)

Loading locations...

相似试验